Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- 3 Feb 2026
- Expected to end
- 30 Jun 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- mindfulness based exposure therapy
- Treatment as Usual (TAU)
- Record updated
- 20 March 2026
Who can take part
- Age
- 16 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to DSM-5 criteria
- Are between 16 and 55 years of age (inclusive)
- Have a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) total score ≥ 16
- Have an education level of junior high school or above
- Are medication-free or have been stabilized on psychotropic medication for at least 8 weeks
- Have sufficient visual and auditory capabilities to complete study assessments
- Are willing to participate and provide written informed consent
Who cannot take part
- Have metal implants contraindicated for MRI (e.g., pacemakers, intracranial clips, metal dentures, arterial stents, joint fixations)
- Meet DSM-5 criteria for any other psychiatric disorder besides OCD
- Have a serious somatic disease, central nervous system disease, or substance abuse history
- Have severe OCD symptoms that prevent completion of assessments
- Exhibit active suicidal ideation or high suicide risk
- Are pregnant, breastfeeding, or planning pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 55 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Obessive-Compulsive Disorder (OCD) is frequently treatment-refractory and imposes a substantial burden on affected individuals. Although Exposure and Response Prevention (ERP) is widely regarded as the first-line intervention, its inherently distressing nature contributes to treatment refusal and premature dropout in a subset of patients. The present study aims to develop and validate a novel intervention, Mindfulness-Based Exposure Therapy (MBET).
Read full original descriptionShow less
In contrast to existing protocols that incorporate mindfulness as an adjunct to ERP and have yielded mixed or limited benefits, this study seeks a theoretically grounded integration of mindfulness and exposure-based principles. We hypothesize that mindfulness training improves emotion regulation, thereby producing a synergistic effect that enhances patients' capacity to engage in and complete exposure tasks.
From a clinical perspective, MBET is intended to offer a more tolerable and acceptable alternative to standard ERP, with the potential to improve treatment adherence and clinical outcomes among patients who experience traditional exposure procedures as excessively distressing.
The 2 groups in the trial
- Experimental : active treatment groupTreatment being tested
Treatment: mindfulness based exposure therapy
- Treatment as usual groupExisting treatment, for comparison
Treatment: Treatment as Usual (TAU)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mindfulness-Based Exposure Group Therapy for Obsessive-compulsive Disorder: A Randomized Controlled Trial
- Fit questions
- Built from NCT07484750, who can take part
- Record updated
- 20 March 2026